Skip to main content
. 2013 Apr 24;8(4):e61598. doi: 10.1371/journal.pone.0061598

Table 2. The differences in sex hormone levels after grouping the subjects by vascular disease.

VD TT FT BT T/E2 E2 E2/SHBG FE2 PROG LH FSH FTI TSI SHBG
Control (n = 150) A 5.19±1.83 0.22±0.08 5.15±1.81 0.19±0.06 29.24±8.45 0.68±0.32 0.60±0.28 274.45±166.13 8.45±4.90 13.84±14.19 0.11±0.03 0.76±0.41 49.64±21.58
B 5.16±0.16 0.22±0.01 5.13±0.16 0.19±0.01 29.14±0.71 0.65±0.03 0.60±0.28 275.05±11.24 9.39±0.49 16.32±1.29 0.11±0.09 0.72±0.03 51.63±1.67
CEVD (n = 31) A 5.02±1.90 0.25±0.14 4.97±1.89 0.19±0.09 27.23±7.97 0.58±0.29 0.50±0.21* 218.51±77.61 11.28±8.83* 21.65±22.15* 0.10±0.03* 0.64±0.42 55.32±22.32
B 5.06±0.35 0.25±0.02 4.99±0.35 0.19±0.01 27.34±1.54 0.61±0.06 0.50±0.02 217.54±24.73 10.55±1.07 19.57±2.84 0.18±0.01 0.68±0.07 53.24±3.67
CAVD (n = 101) A 5.19±1.82* 0.21±0.08* 4.96±1.87* 0.18±0.07 28.40±8.10 0.64±0.30 0.52±0.21 243.71±116.04 9.37±6.23 17.29±16.81 0.10±0.03* 0.66±0.35* 49.75±18.29
B 4.94±0.19 0.21±0.01 4.94±0.19 0.18±0.01 28.44±0.84 0.65±0.03 0.51±0.02 242.96±13.44 9.17±0.58 17.01±1.54 0.11±0.00 0.68±0.04 49.03±2.01
TVD (n = 54) A 5.03±2.02 0.21±0.09 4.99±1.99 0.18±0.08 28.51±8.87 0.58±0.30* 0.52±0.23 225.45±166.13* 10.89±6.64** 20.70±17.30** 0.09±0.03** 0.61±0.37* 57.86±22.66
B 5.01±0.27 0.21±0.01 4.94±0.27 0.18±0.01 28.60±1.17 0.62±0.04 0.51±0.02 227.18±18.93 9.52±0.82 17.08±2.17 0.10±0.00 0.61±0.05 54.56±2.81
EVD (n = 183) A 5.00±1.93 0.22±0.10 4.95±1.91 0.18±0.08 28.24±8.27 0.64±0.31* 0.52±0.22 234.34±101.73** 10.12±6.84* 18.98±17.91** 0.10±0.03** 0.64±0.37** 52.98±20.52
B 4.98±0.14 0.22±0.01 4.95±0.14 0.18±0.01 28.31±0.63 0.63±0.02 0.51±0.02 234.47±10.12 9.49±0.44 17.45±1.16 0.10±0.00 0.67±0.03 51.26±1.51

VD: vascular diseases; CEVD: cerebrovascular disease; CAVD: cardiovascular disease; TVD: both CEVD and CAVD; EVD: more than one type of vascular diseases.

A represents the difference in sex hormone levels in patients with various vascular diseases without adjusting for age and smoke.

B represents the difference in sex hormone levels in patients with various vascular diseases after adjusting for age and smoke.